% alzhub.org library filter % Source: https://alzhub.org/research?author=Lle%C3%B3+A % 13 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{lleo2018-29554190, author = {Lleó, A. and Irwin, D. J. and Illán-Gala, I. and McMillan, C. T. and Wolk, D. A. and Lee, E. B. and Van Deerlin, V. M. and Shaw, L. M. and others}, title = {{A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes}}, journal = {JAMA neurology}, year = {2018}, doi = {10.1001/jamaneurol.2018.0118}, pmid = {29554190}, url = {https://doi.org/10.1001/jamaneurol.2018.0118} } @article{suarezcalvet2016-26941262, author = {Suárez-Calvet, M. and Kleinberger, G. and MÁ, Araque Caballero and Brendel, M. and Rominger, A. and Alcolea, D. and Fortea, J. and Lleó, A. and others}, title = {{sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers}}, journal = {EMBO molecular medicine}, year = {2016}, doi = {10.15252/emmm.201506123}, pmid = {26941262}, url = {https://doi.org/10.15252/emmm.201506123} } @article{leuzy2016-27401520, author = {Leuzy, A. and Chiotis, K. and Hasselbalch, S. G. and Rinne, J. O. and de Mendonça, A. and Otto, M. and Lleó, A. and Castelo-Branco, M. and others}, title = {{Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study}}, journal = {Brain : a journal of neurology}, year = {2016}, doi = {10.1093/brain/aww160}, pmid = {27401520}, url = {https://doi.org/10.1093/brain/aww160} } @article{alcolea2023-36878698, author = {Alcolea, D. and Beeri, M. S. and Rojas, J. C. and Gardner, R. C. and Lleó, A.}, title = {{Blood Biomarkers in Neurodegenerative Diseases: Implications for the Clinical Neurologist}}, journal = {Neurology}, year = {2023}, doi = {10.1212/wnl.0000000000207193}, pmid = {36878698}, url = {https://doi.org/10.1212/wnl.0000000000207193} } @article{lleo2021-34262030, author = {Lleó, A. and Zetterberg, H. and Pegueroles, J. and Karikari, T. K. and Carmona-Iragui, M. and Ashton, N. J. and Montal, V. and Barroeta, I. and others}, title = {{Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome}}, journal = {Nature communications}, year = {2021}, doi = {10.1038/s41467-021-24319-x}, pmid = {34262030}, url = {https://doi.org/10.1038/s41467-021-24319-x} } @article{vilaplana2020-32291295, author = {Vilaplana, E. and Rodriguez-Vieitez, E. and Ferreira, D. and Montal, V. and Almkvist, O. and Wall, A. and Lleó, A. and Westman, E. and others}, title = {{Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease}}, journal = {Neurology}, year = {2020}, doi = {10.1212/wnl.0000000000009405}, pmid = {32291295}, url = {https://doi.org/10.1212/wnl.0000000000009405} } @article{zwan2016-26468410, author = {Zwan, M. D. and Rinne, J. O. and Hasselbalch, S. G. and Nordberg, A. and Lleó, A. and Herukka, S. K. and Soininen, H. and Law, I. and others}, title = {{Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study}}, journal = {Neurology}, year = {2016}, doi = {10.1212/wnl.0000000000002081}, pmid = {26468410}, url = {https://doi.org/10.1212/wnl.0000000000002081} } @article{colomcadena2013-24226269, author = {Colom-Cadena, M. and Gelpi, E. and Charif, S. and Belbin, O. and Blesa, R. and Martí, M. J. and Clarimón, J. and Lleó, A.}, title = {{Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies}}, journal = {Journal of neuropathology and experimental neurology}, year = {2013}, doi = {10.1097/nen.0000000000000018}, pmid = {24226269}, url = {https://doi.org/10.1097/nen.0000000000000018} } @article{garciaayllon2017-28559572, author = {García-Ayllón, M. S. and Lopez-Font, I. and Boix, C. P. and Fortea, J. and Sánchez-Valle, R. and Lleó, A. and Molinuevo, J. L. and Zetterberg, H. and others}, title = {{C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease}}, journal = {Scientific reports}, year = {2017}, doi = {10.1038/s41598-017-02841-7}, pmid = {28559572}, url = {https://doi.org/10.1038/s41598-017-02841-7} } @article{lleo2021-34183050, author = {Lleó, A. and Carmona-Iragui, M. and Videla, L. and Fernández, S. and Benejam, B. and Pegueroles, J. and Barroeta, I. and Altuna, M. and others}, title = {{VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome}}, journal = {Alzheimer's research \& therapy}, year = {2021}, doi = {10.1186/s13195-021-00861-0}, pmid = {34183050}, url = {https://doi.org/10.1186/s13195-021-00861-0} } @article{carmonairagui2019-31278851, author = {Carmona-Iragui, M. and Videla, L. and Lleó, A. and Fortea, J.}, title = {{Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis}}, journal = {Developmental neurobiology}, year = {2019}, doi = {10.1002/dneu.22709}, pmid = {31278851}, url = {https://doi.org/10.1002/dneu.22709} } @article{lleo2021-870cda97, author = {Lleó, A. and Carmona-Iragui, M. and Videla, L. and Fernández, S. and Benejam, B. and Pegueroles, J. and Barroeta, I. and Altuna, M. and others}, title = {{VAMP-2 Is a Surrogate Cerebrospinal Fluid Marker of Alzheimer-related Cognitive Impairment in Adults With Down Syndrome}}, journal = {Alzheimer's research \& therapy}, year = {2021}, doi = {10.21203/rs.3.rs-340117/v1}, url = {https://doi.org/10.21203/rs.3.rs-340117/v1} } @article{lleo2006-16409164, author = {Lleó, A. and Greenberg, S. M. and Growdon, J. H.}, title = {{Current pharmacotherapy for Alzheimer's disease}}, journal = {Annual review of medicine}, year = {2006}, doi = {10.1146/annurev.med.57.121304.131442}, pmid = {16409164}, url = {https://doi.org/10.1146/annurev.med.57.121304.131442} }